Affiliation: University Hospital
- Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable toolA Tsianakas
Department of Dermatology, University Hospital of Muenster, Muenster, Germany
Br J Dermatol 169:160-3. 2013..Though liver metastases dominate as the primary site for metastasis, the existence of primary skin metastases is still under discussion but has been reported in only a few studies...
- [Werner's syndrome]A Tsianakas
Universitatsklinikum Munster, Klinik und Poliklinik für Hautkrankheiten
Dtsch Med Wochenschr 132:91-4. 2007..A 49-year-old man of German parentage with Werner's syndrome (including insulin-dependent type 2 diabetes mellitus) was treated in our department for extensive ulcers on his lower legs...
- Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitisAthanasios Tsianakas
Department of Dermatology, University of Muenster, Muenster, Germany
J Am Acad Dermatol 61:701-6. 2009..Thus, for reasons beyond potential loss of vision, physicians should be alert for symptoms of GCA as only timely diagnosis and immediate therapy may prevent serious complications and increased mortality...
- The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma?Athanasios Tsianakas
Department of Dermatology, University of Munster, Germany
J Dtsch Dermatol Ges 7:671-9. 2009..We describe legal aspects of compassionate use are discussed, taking two of our cases as examples. Finally, examples for necessary documents to apply for compassionate use are provided...
- Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alphaA Tsianakas
Division of Paediatric Dermatology, Department of Dermatology, University of Hamburg, Martinistr 52, D 20246 Hamburg, Germany
Br J Dermatol 152:794-9. 2005..We hypothesize that in future cases, treatment with TNF-alpha antagonists might represent a reasonable alternative to high-dose immunosuppressive therapy...
- A novel compound heterozygous mutation in Werner syndrome results in WRN transcript decayF B Muller
Department of Dermatology, University of Cologne, Kerpener Str 62, 50937 Koln, Germany
Br J Dermatol 152:1030-2. 2005..Werner syndrome (WS) is a rare autosomal recessive progeroid disorder caused by mutations of the WRN gene encoding a protein of the RecQ-type family of DNA helicases...